Showing 1 - 10 of 269
Persistent link: https://www.econbiz.de/10011637483
Persistent link: https://www.econbiz.de/10012703821
This chapter surveys the costs, risks, and challenges encountered in the progressive discovery and development of new pharmaceuticals. The changing methods by which drugs are discovered, the links between companies and academic science, the changing character of public regulation, and the sharp...
Persistent link: https://www.econbiz.de/10014025164
Persistent link: https://www.econbiz.de/10013273606
Persistent link: https://www.econbiz.de/10014483459
Persistent link: https://www.econbiz.de/10014479064
Persistent link: https://www.econbiz.de/10012430562
. Fostering competition by removing regulatory barriers and improving public procurement would help. In addition, innovation …
Persistent link: https://www.econbiz.de/10010374405
, along with a more complex set of innovation incentives. This chapter presents background on medical device regulation … adverse events and recalls), and concludes with a discussion of the implications of regulation for innovation incentives in …
Persistent link: https://www.econbiz.de/10013477189
The purpose of this paper is to try to shed some new light on the current industrial policy crisis. This paper proposes that the industrial policy debate is shaped by knowledge about the functioning of the underlying industrial structure, which in turn is the Gegenstand of scholars in the field...
Persistent link: https://www.econbiz.de/10005136586